ARCHIVES

FDA Approves Votrient For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

October 21, 1983

NCI Branch Chiefs, ACCI Join Support For DeVita

June 25, 1981

Congress Provides 7% Increase For NIH, 6.6% for NCI, In FY98 Appropriation

November 14, 1997

Come Out of Labs and Join Picket Pines, Congressman Urges

March 30, 1990

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

November 28, 1975

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994